Company: ERAS
Filing Date: 2025-08-12
Form Type: 10-Q
Source: 0001193125-25-178996
Chunk: 7

Company: Erasca, Inc.
Filing Date: 2025-08-12
Form: 10-Q
Item: Item 5
Chunk 7
---
Rule 10b5-1 Trading Plans

During the three months ended June 30, 2025, none of our officers (as defined in Rule 16a–1(f)) or directors adopted, materially modified or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each such term is defined in Item 408 of Regulation S-K.

At the Market Sales Agreements

2022 Sale Agreement

On August 11, 2022, we entered into an Open Market Sale Agreement (the Sale Agreement), with Jefferies LLC (the Agent), pursuant to which we could offer and sell shares of our common stock having an aggregate offering price of up to $200 million from time to time, in an “at-the-market offering” (2022 ATM Offering) through the Agent. In connection with the 2022 ATM Offering, we filed a sales agreement prospectus (the 2022 ATM Prospectus) with a shelf registration statement on Form S-3 (File No. 333-266802), which was declared effective by the SEC on August 18, 2022. In connection with the Amended and Restated Sale Agreement (defined below), effective August 12, 2025, we amended and restated the Sale Agreement, and we have discontinued all offers and sales of shares of our common stock under the Sale Agreement and the 2022 ATM Prospectus. As of June 30, 2025, we had $178.1 million of shares available for sale under the 2022 ATM Offering.